Skin necrosis following sclerotherapy. Part 1: Differential diagnosis based on classification of pathogenic mechanisms.
Kang M, Yang A, Hannaford P, Connor D, Parsi K.
Phlebology. 2022 Jul;37(6):409-424. doi: 10.1177/02683555221088101. Epub 2022 May 3.
Skin Necrosis Due to the Extravasation of Irritant Anticancer Agents.
Okuda H, Masatsugu A, Sijimaya T, Arai R.
Intern Med. 2018 Mar 1;57(5):757-760. doi: 10.2169/internalmedicine.9329-17. Epub 2017 Nov 1.
Skin necrosis following sclerotherapy. Part 2: Risk minimisation and management strategies.
Kang M, Yang A, Hannaford P, Connor D, Parsi K.
Phlebology. 2022 Oct;37(9):628-643. doi: 10.1177/02683555221125596. Epub 2022 Sep 15.
Possibility of Taking an Offensive Stance in Extravasation Injury: Effects of Fat Injection in Vesicant (Doxorubicin) Induced Skin Necrosis Model in Rats.
Bicer A, Ercin BS, Gürler T, Yiğittürk G, Uyanikgil Y, Cetin EO.
J Invest Surg. 2022 Apr;35(4):801-808. doi: 10.1080/08941939.2021.1966142. Epub 2021 Aug 17.
Arginine extravasation leading to skin necrosis.
Abraham MB, van der Westhuyzen J, Khanna V.
J Paediatr Child Health. 2012 Mar;48(3):E96-7. doi: 10.1111/j.1440-1754.2011.02074.x. Epub 2011 Apr 29.
Prevention and management of extravasation of cytotoxic drugs.
Bertelli G.
Drug Saf. 1995 Apr;12(4):245-55. doi: 10.2165/00002018-199512040-00004.
Complications of intravenous fluorescein injections.
Lipson BK, Yannuzzi LA.
Int Ophthalmol Clin. 1989 Fall;29(3):200-5. doi: 10.1097/00004397-198902930-00011.
Vincristine-induced dermal toxicity is significantly reduced when the drug is given in liposomes.
Boman NL, Tron VA, Bally MB, Cullis PR.
Cancer Chemother Pharmacol. 1996;37(4):351-5. doi: 10.1007/s002800050396.
Extravasation: a dreaded complication of chemotherapy.
Schrijvers DL.
Ann Oncol. 2003;14 Suppl 3:iii26-30. doi: 10.1093/annonc/mdg744.
Histologic changes induced in skin by extravasation of doxorubicin (adriamycin).
Bhawan J, Petry J, Rybak ME.
J Cutan Pathol. 1989 Jun;16(3):158-63. doi: 10.1111/j.1600-0560.1989.tb00032.x.
